Mark T Iwicki is of Merus N.V.. Currently has a direct ownership of 0 shares of MRUS, which is worth approximately $0. The most recent transaction as insider was on Dec 12, 2025, when has been sold 73,576 shares (Common Shares) at a price of $97.0 per share, resulting in proceeds of $7,136,872. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Mark T Iwicki Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2025
SELL
Disposition due to a tender of shares in a change of control transaction
$7,136,872 $97.0 p/Share
73,576 Reduced 100.0%
0 Common Shares
Apr 14 2023
BUY
Exercise of conversion of derivative security
$534,897 $7.27 p/Share
73,576 Added 50.0%
73,576 Common Shares

Also insider at

KALA
Kala Pharmaceuticals, Inc. Healthcare
PULM
Pulmatrix, Inc. Healthcare
AKRO
Akero Therapeutics, Inc. Healthcare
AVTE
Aerovate Therapeutics, Inc. Healthcare
IKT
Inhibikase Therapeutics, Inc. Healthcare
THRD
Third Harmonic Bio, Inc. Healthcare
FIXX
Homology Medicines, Inc. Healthcare
MTI

Mark T Iwicki

Utretcht, P7

Track Institutional and Insider Activities on MRUS

Follow Merus N.V. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRUS shares.

Notify only if

Insider Trading

Get notified when an Merus N.V. insider buys or sells MRUS shares.

Notify only if

News

Receive news related to Merus N.V.

Track Activities on MRUS